Targeted Radionuclide Therapy of Human Tumors

By Gudkov Sergey V.   Shilyagina Natalya Yu.   Vodeneev Vladimir A.   Zvyagin Andrei V.  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2015-12 ,pp. : 33-33

MDPI

Access to resources Recommend Favorite

A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?

By de Kruijff Robin M.   Wolterbeek Hubert T.   Denkova Antonia G.  

Pharmaceuticals, Vol. 8, Iss. 2, 2015-06 ,pp. : 321-336

MDPI

Access to resources Recommend Favorite

¹⁸⁸Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept

By Chang Chia-Ming   Lan Keng-Li   Huang Wen-Sheng   Lee Yi-Jang   Lee Te-Wei   Chang Chih-Hsien   Chuang Chi-Mu  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 903-903

MDPI

Access to resources Recommend Favorite

Human Anti-Oxidation Protein A1M—A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy

By Ahlstedt Jonas   Tran Thuy A.   Strand Sven-Erik   Gram Magnus   Åkerström Bo  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 30309-30320

MDPI

Access to resources Recommend Favorite

A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice

By Pellegrini Giovanni   Siwowska Klaudia   Haller Stephanie   Antoine Daniel J.   Schibli Roger   Kipar Anja   Müller Cristina  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-06 ,pp. : 57-57

MDPI

Access to resources Recommend Favorite